Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 13/20 | 0.33 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TLR4 | O00206 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17614853 | 1.00 | CYP2C9 (0.35) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL1311026 | 1.00 | CYP2C9 (0.35) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL15203882 | 1.00 | CYP2C9 (0.35) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL4400193 | 1.00 | CYP2C9 (0.35) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL12706520 | 1.00 | CYP2C9 (0.35) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL22269486 | 0.99 | CYP2C9 (0.35) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL22277463 | 0.99 | CYP2C9 (0.35) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL12733782 | 0.96 | CYP2C9 (0.38) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL3274912 | 0.96 | CYP2C9 (0.38) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL18134228 | 0.96 | CYP2C9 (0.38) | CYP2C9ALDH1A1MAPTLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3469576-B1 | MULTI-LAYER DISPLAY WITH COLOR AND CONTRAST ENHANCEMENT | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-07-03 | — | — | EP | disclosed |
| US-10565925-B2 | Full color display with intrinsic transparency | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-02-18 | — | — | US | disclosed |
| US-10554962-B2 | Multi-layer high transparency display for light field generation | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-02-04 | — | — | US | disclosed |
| US-10453371-B2 | Multi-layer display with color and contrast enhancement | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-10-22 | — | — | US | disclosed |
| US-10375365-B2 | Projection system with enhanced color and contrast | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-08-06 | — | — | US | disclosed |
| EP-3479163-A1 | MULTI-LAYER HIGH TRANSPARENCY DISPLAY FOR LIGHT FIELD GENERATION | Samsung Electronics Co., Ltd. (KR) | 2019-05-08 | — | — | EP | disclosed |
| EP-3469576-A1 | MULTI-LAYER DISPLAY WITH COLOR AND CONTRAST ENHANCEMENT | Samsung Electronics Co., Ltd. (KR) | 2019-04-17 | — | — | EP | disclosed |
| EP-3469791-A1 | PROJECTION SYSTEM WITH ENHANCED COLOR AND CONTRAST | Samsung Electronics Co., Ltd. (KR) | 2019-04-17 | — | — | EP | disclosed |
| EP-3455845-A1 | FULL COLOR DISPLAY WITH INTRINSIC TRANSPARENCY | Samsung Electronics Co., Ltd. (KR) | 2019-03-20 | — | — | EP | disclosed |
| US-20170310956-A1 | MULTI-LAYER HIGH TRANSPARENCY DISPLAY FOR LIGHT FIELD GENERATION | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-10-26 | — | — | US | disclosed |
| EP-2479162-A1 | LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20120018672-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO PETROCHEMICAL CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| US-7758931-B2 | Chlorofluorobenzene liquid crystal compound, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-07-20 | — | — | US | disclosed |
| EP-2199270-A1 | LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | Chisso Corporation (JP) | 2010-06-23 | — | — | EP | disclosed |
| US-20090264683-A1 | CHLOROFLUOROBENZENE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2009-10-22 | — | — | US | disclosed |
| US-7569258-B2 | Chlorofluorobenzene liquid crystal compound, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2009-08-04 | — | — | US | disclosed |
| US-20060198968-A1 | cyclohexenylene compounds which have a phenylene ring both fluoro and chloro substituted; wide temperature range; heat and light stable; small viscosity, large optical anisotropy; suitable negative dielectric anisotropy and excellent compatibility with other liquid crystal compounds; short response times | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2006-09-07 | — | — | US | disclosed |
| US-5980778-A | STABILITY, COMPATIBILITY | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0768361-A1 | Liquid crystal composition and liquid crystal display element comprising the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1997-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CXCR1, OCIAD1, LEO1 | CYP2C9 585/4885ALDH1A1 313/4885MAPT 1566/4885 |
| US-20090264683-A1 | CHLOROFLUOROBENZENE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CCND3, CCND1, SLFN12 | CYP2C9 2402/4885ALDH1A1 2030/4885MAPT 2893/4885 |
| US-20120018672-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | ROCK2, ROCK1, LEF1 | CYP2C9 2917/4885ALDH1A1 1435/4885MAPT 672/4885 |
| US-20060198968-A1 | cyclohexenylene compounds which have a phenylene ring both fluoro and chloro substituted; wide temperature range; heat and light stable; small viscosity, large optical anisotropy; suitable negative dielectric anisotropy and excellent compatibility with other liquid crystal compounds; short response times | CCND3, CCND1, TCF12 | CYP2C9 2535/4885ALDH1A1 2356/4885MAPT 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.